World Solve

Even mild traumatic brain injuries can cause lasting cognitive effects that current treatments struggle to fully reverse. A better understanding of brain recovery mechanisms could open new treatment paths.

A significant share of patients with depression don't respond adequately to standard treatments, and doctors currently have limited ability to predict who will respond to which approach. Better personalized treatment matching remains an open challenge.

Glaucoma often causes irreversible vision loss before it's diagnosed, since early stages typically have no noticeable symptoms. Better early detection and prevention methods remain a pressing unmet need in eye care.

Effective treatments for hepatitis B exist, but cost and access remain out of reach for many of the hundreds of millions of people living with the infection globally, particularly in lower-income regions. Closing this access gap remains unresolved.

The same virus or bacteria can cause mild illness in most people while triggering severe, sometimes life-threatening complications in others, and we still don't fully understand why. This gap makes predicting and preventing severe outcomes difficult.

Current treatments for multiple sclerosis can reduce the frequency and severity of flare-ups but can't stop or reverse the underlying immune attack on the nervous system. A true cure remains an unmet goal after decades of research.

By the time visible symptoms of Parkinson's appear, significant neurological damage has usually already occurred, limiting how much treatment can help. Detecting the disease years earlier could open the door to more effective intervention.

Existing treatments for hair loss can slow the process for some people but rarely reverse it completely, and the underlying biology of hair follicle loss isn't fully understood. A true prevention or reversal method remains undiscovered.

Kidney disease often advances silently for years before symptoms appear, and by the time it's caught, treatment options are limited mainly to slowing further decline. Catching and reversing it earlier remains an open medical challenge.

Drug-resistant tuberculosis requires longer, more expensive, and more toxic treatment regimens that many patients in affected regions simply can't access or complete. This keeps a preventable disease deadly in the parts of the world least equipped to fight it.

Patients sometimes continue to experience pain months or years after the original injury has healed, suggesting the nervous system itself has changed in ways doctors don't fully understand. Solving this could transform treatment for chronic pain conditions.

Lung cancer screening guidelines are generally built around smoking history, but a meaningful share of cases occur in people who never smoked at all and often go undetected until later stages. Better screening approaches for this group remain underdeveloped.

Despite strict hygiene protocols, patients still frequently contract infections during hospital stays that they didn't have when they arrived. Closing this gap could save both lives and enormous healthcare costs.

Many new parents experience postpartum depression that goes undiagnosed or untreated for months, affecting both their wellbeing and their infant's early development. Faster detection and more accessible treatment remain unmet needs.

A large share of pregnancy loss has no clearly identifiable cause, leaving expecting parents without answers or ways to prevent it happening again. Understanding these unexplained cases remains a significant gap in reproductive medicine.

Food allergies have been rising for reasons researchers still can't fully explain, and existing treatments mostly manage symptoms after exposure rather than removing the risk entirely. A true prevention or cure remains elusive.

Ovarian cancer is often called a silent disease because symptoms don't appear until it has advanced significantly. Early detection tools remain far behind those available for other common cancers.

Emerging gene therapies show promise but remain extremely expensive and inaccessible to the vast majority of people living with sickle cell disease worldwide, especially in Africa where it's most common. Making a real cure affordable and available remains unsolved.

Pancreatic cancer often shows no clear symptoms until it has already spread, making it one of the deadliest common cancers. An affordable early screening method could dramatically improve survival rates.

Millions of people live with persistent, disabling fatigue that doctors struggle to diagnose clearly or treat effectively. The underlying biology remains poorly understood despite decades of patient reports.